Finch Therapeutics Group, Inc. (FNCH)
USD 10.71
(-3.51%)
USD 10.71
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -31.5 Million | -74.85 Million | -67.13 Million | -31.32 Million | -17.32 Million |
| Net Income | -74.75 Million | -114.64 Million | -58.16 Million | -39.34 Million | -20.75 Million |
| Depreciation & Amortization | 1.52 Million | 5.5 Million | 2.3 Million | 790 Thousand | 482 Thousand |
| Deferred income taxes | -3.46 Million | - | -1.83 Million | - | - |
| Stock-based compensation | 1.92 Million | 7.84 Million | 4.16 Million | 3.09 Million | 606 Thousand |
| Change in working capital | -5.42 Million | -1.56 Million | -14.51 Million | 4.11 Million | 2.2 Million |
| Other non-cash items | 48.68 Million | 28 Million | 913 Thousand | 13 Thousand | 140 Thousand |
| Investing Cash Flow | 1.32 Million | -2.18 Million | -15.92 Million | -2.63 Million | -973 Thousand |
| Investments in PPE | - | -2.18 Million | -15.98 Million | -2.63 Million | -1 Million |
| Acquisitions | 1.32 Million | - | 62 Thousand | - | 32 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 1.32 Million | - | 62 Thousand | - | 31.99 Thousand |
| Financing Cash Flow | -16.15 Million | 14.87 Million | 119.11 Million | 91.47 Million | 53.3 Million |
| Debt repayment | -16.15 Million | -22 Thousand | -27 Thousand | -47 Thousand | -71 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -245 Thousand |
| Common Stock Issuance | - | 289 Thousand | 118.57 Million | 59 Thousand | 150 Thousand |
| Other Financing Activities | -16.15 Million | 14.6 Million | 561 Thousand | 91.46 Million | 53.61 Million |
| Accounts receivables | 143 Thousand | 350 Thousand | 540 Thousand | 143 Thousand | 1.2 Million |
| Accounts payables | -956 Thousand | -2.25 Million | 2.26 Million | 440 Thousand | -1.05 Million |
| Inventory | - | - | -3.68 Million | 255 Thousand | 43 Thousand |
| Other working capital | -4.6 Million | 345 Thousand | -13.63 Million | 3.27 Million | 2.02 Million |
| Cash at beginning of period | 71.03 Million | 135.96 Million | 99.9 Million | 42.39 Million | 7.38 Million |
| Cash at end of period | 25.12 Million | 73.8 Million | 135.96 Million | 99.9 Million | 42.39 Million |
| Capital Expenditure | - | -2.18 Million | -15.98 Million | -2.63 Million | -1 Million |
| Effect of forex changes on cash | 419 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -45.91 Million | -62.16 Million | 36.05 Million | 57.51 Million | 35 Million |
| Free Cash Flow | -31.5 Million | -77.03 Million | -83.11 Million | -33.96 Million | -18.32 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.83 Million | -3.87 Million | -3.04 Million | -74.75 Million | -2.41 Million | -5.35 Million |
| Depreciation & Amortization | 44 Thousand | 43 Thousand | 44 Thousand | 1.52 Million | 52 Thousand | 57 Thousand |
| Deferred income taxes | - | - | -419 Thousand | -3.46 Million | 22 Thousand | -797 Thousand |
| Stock-based compensation | 15 Thousand | 28 Thousand | 114 Thousand | 1.92 Million | 335 Thousand | 300 Thousand |
| Change in working capital | -528 Thousand | -1.12 Million | -786 Thousand | -5.42 Million | -3.97 Million | -3.56 Million |
| Other non-cash items | 577 Thousand | 774 Thousand | 382 Thousand | 48.68 Million | 719 Thousand | 205 Thousand |
| Investing Cash Flow | - | - | 51 Thousand | 1.32 Million | 20 Thousand | 1.27 Million |
| Investments in PPE | - | - | 14 Thousand | - | - | - |
| Acquisitions | - | - | 37 Thousand | 1.32 Million | 20 Thousand | 1.27 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 37 Thousand | 1.32 Million | 20 Thousand | 1.27 Million |
| Financing Cash Flow | - | - | - | -16.15 Million | - | 4000.00 |
| Debt repayment | - | - | -1.15 Million | -16.15 Million | - | -4000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 1.15 Million | -16.15 Million | - | 8000.00 |
| Accounts receivables | - | - | -1000.00 | 143 Thousand | - | 107 Thousand |
| Accounts payables | -18 Thousand | -94 Thousand | -216 Thousand | -956 Thousand | -76 Thousand | -2.12 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -510 Thousand | -1.02 Million | -569 Thousand | -4.6 Million | -3.89 Million | -1.55 Million |
| Cash at beginning of period | 23.11 Million | 25.12 Million | 28.77 Million | 71.03 Million | 36.36 Million | 44.25 Million |
| Cash at end of period | 18.38 Million | 20.76 Million | 25.12 Million | 25.12 Million | 31.12 Million | 36.36 Million |
| Capital Expenditure | - | - | 14 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | -1000.00 | 419 Thousand | - | 1000.00 |
| Net cash flow / Change in cash | -4.72 Million | -4.36 Million | -3.65 Million | -45.91 Million | -5.24 Million | -7.88 Million |
| Free Cash Flow | -4.72 Million | -4.36 Million | -3.69 Million | -31.5 Million | -5.26 Million | -9.15 Million |
4911
FYMNF
BORUF
CNTHN
SNIRF
UFO